This article addresses the critical challenge of data fragmentation in cancer surveillance, which impedes research and drug development.
This article provides a comprehensive methodological framework for researchers and drug development professionals to systematically identify, analyze, and prioritize implementation determinants in cancer control.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on establishing and optimizing protected research time.
This article provides a comprehensive framework for researchers and drug development professionals aiming to design and implement robust cancer clinical trials in resource-limited settings.
This article provides a comprehensive analysis of the bureaucratic and systemic barriers hindering international collaboration in cancer research, with a specific focus on perspectives from low- and middle-income countries (LMICs)...
This article addresses the critical challenge of managing competing priorities in cancer research workflows, a key concern for researchers, scientists, and drug development professionals.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on establishing and optimizing international collaborative networks in cancer research.
This article explores the transformative role of agile science methods in cancer implementation research, addressing a critical need for more adaptive and efficient approaches to integrating evidence-based interventions into routine...
This article provides a comprehensive guide for researchers and drug development professionals on applying user-centered design (UCD) to create impactful cancer quality improvement tools.
The Multiphase Optimization Strategy (MOST) is an engineering-inspired framework for developing, optimizing, and evaluating multicomponent interventions, offering a systematic alternative to the traditional 'bundled' randomized controlled trial.